TMCI · ISSUER CIK 1630627
TREACE MEDICAL CONCEPTS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 4 TREACE MEDICAL CONCEPTS, INC. insiders reported $247K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Treace John T. (Chief Executive Officer, Director, 10% Owner), with $247K.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$247KInsider buying
$0.00Insider selling
+$247KNet open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202619:30 | Oct 24, 2026 | TMCI | Chief Innovation Officer | F · Tax | — | −207 | 634,656 | -0% | — | ||
| Oct 2, 202619:00 | Sep 30, 2026 | TMCI | Chief Legl & Comp Off, CorpSec | F · Tax | — | −25,457 | 753,226 | -3% | — | ||
| Aug 24, 202617:00 | Aug 24, 2026from Aug 20, 2026 | TMCI | Chief Executive Officer, Director, 10% Owner | P · Buy | $4.41 | +55,944 | 7,404,383 | +1% | +$247K | -8.0% | +14.8% |
| Aug 12, 202618:00 | Aug 9, 2026 | TMCI | Chief Innovation Officer | F · Tax | — | −9,814 | 679,863 | -1% | — | ||
| Aug 12, 202617:30 | Aug 9, 2026 | TMCI | Chief Financial Officer | F · Tax | — | −37,102 | 914,900 | -4% | — | ||
| Aug 12, 202617:30 | Aug 9, 2026 | TMCI | Chief Legl & Comp Off, CorpSec | F · Tax | — | −16,253 | 778,683 | -2% | — |